- Why is this medication being recommended?
- What special precautions should I follow?
- What side effects can this medication cause?
- What monitoring will I need?
Pirfenidone (Esbriet) was approved for the treatment of IPF in the fall of 2014. The recommended dose is 801 mg (3 pills) three times daily with food.
Pirfenidone is not a cure for IPF. However, it has been shown to slow the decline of lung function over time.
This medication is available to patients through specialty pharmacies. Additional information can be found at www.esbriet.com.
You should take Pirfenidone three times daily with food.
Pirfenidone may cause many side effects. The most common side effects patients experience is nausea/vomiting. Taking this medication with food or using an anti-nauseant medication may help reduce side effects of nausea and/or vomiting. However, if these symptoms persist despite these measures, your doctor may tell you to reduce your dose of Pirfenidone, temporarily stop the medication, or discontinue the medication all together.
Pirfenidone may also cause photosensitivity and/or rash. Always wear sunscreen active against both UVA and UVB to protect you from the sun. Avoid direct sun exposure and wear a hat and long sleeved clothing when outside.
Before starting treatment with Pirfenidone, your doctor will check your liver function (AST, ALT and bilirubin). Your liver function tests will be checked every month for the first three months you are on the medication. After that, liver function tests should be checked every three months. If your liver function tests become abnormal, your doctor may ask you to reduced your dose, temporarily stop the medication or discontinue it all together.
Your doctor will also monitor your lung function periodically to help assess your response to the medication.
UCSF Health medical specialists have reviewed this information. It is for educational purposes only and is not intended to replace the advice of your doctor or other health care provider. We encourage you to discuss any questions or concerns you may have with your provider.
Interstitial Lung Disease (ILD) Program
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143
Commonly asked questions regarding Methotrexate including, recommendation, precautions, possible side effects, suggested monitoring and more.
Commonly asked questions regarding Mycophenolate including recommendation, precautions, possible side effects, suggested monitoring and more.
Commonly asked questions regarding Prednisone including, the reason for recommendation, special precautions, possible side effects, monitoring, and more.
GERD in ILD Patients
Many studies have shown a link between GERD & lung disease, including interstitial lung disease (ILD). The reason for this relationship is unclear. Learn more.
ILD Nutrition Manual
Nutrition Manual for Interstitial Lung Disease including, General Guidelines for Eating Healthy, Body Mass Index, Increasing Protein in Your Diet and more.
Pulmonary Hypertension and Interstitial Lung Disease
Pulmonary hypertension, or PH, occurs when blood pressure in the lungs becomes elevated, and can be caused by a thickening of the pulmonary artery walls.
Pulmonary Rehabilitation for ILD Patients
Pulmonary rehabilitation is a comprehensive program for lung disease patients whose symptoms are impacting their everyday activities. Learn more here.
Find Supplemental Oxygen Resources including, The Need for Supplemental Oxygen, Your Oxygen Equipment, Oxygen Safety, Traveling With Oxygen, and more.